Interaction of CT 1341 (Althesin) with neuromuscular blocking drugs.
D000530:Alfaxalone Alfadolone Mixture / Q000494:pharmacology*; D000818:Animals; D001965:Bromides / Q000494:pharmacology; D002712:Chlorides / Q000494:pharmacology; D004347:Drug Interactions; D005703:Gallamine Triethiodide / Q000494:pharmacology; D006801:Humans; D009388:Neostigmine / Q000494:pharmacology; D009466:Neuromuscular Blocking Agents / Q000494:pharmacology*; D009469:Neuromuscular Junction / Q000187:drug effects*; D010197:Pancuronium / Q000494:pharmacology; D011277:Pregnanediones / Q000494:pharmacology*; D051381:Rats; D013390:Succinylcholine / Q000494:pharmacology; D014403:Tubocurarine / Q000494:pharmacology
D001965:Bromides; D002712:Chlorides; D009466:Neuromuscular Blocking Agents; D011277:Pregnanediones; D009388:Neostigmine; D000530:Alfaxalone Alfadolone Mixture; D013390:Succinylcholine; D010197:Pancuronium; D005703:Gallamine Triethiodide; D014403:Tubocurarine